Moneycontrol
HomeNewsBusinessCOVID-19 impact: Warehousing demand may take a hit in short term
Trending Topics

COVID-19 impact: Warehousing demand may take a hit in short term

Automobile, consumer durables and engineering are some segments that will experience a slowdown due to the outbreak, thus hitting demand for warehouses, Knight Frank India has said in a report.

July 02, 2020 / 13:03 IST
Story continues below Advertisement
(Image courtesy: Embassy Industrial Parks)

The demand for warehouses is expected to fall in the short term and rents, too, will be under pressure due to the coronavirus pandemic but the segment has overall seen healthy growth in the last three years, a report has said.

On the institutional investment side, the sector has seen investment volume going from 125 million dollars in 2016 to 2.3 billion dollars in 2017. In 2018 and 2019, it was recorded at 2.2 billion dollars and 1.8 billion dollars, respectively, India Warehousing Market Report–2020 by property consultants Knight Frank India has said.

Story continues below Advertisement

In 2020, the investor activity was subdued on account of the pandemic, it said.

“Despite the economic slowdown and the pandemic, warehousing market has remained largely resilient, recording a growth of 44 percent CAGR in the last three years,” said Shishir Baijal, chairman and managing director, Knight Frank India.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show